| Original language | English |
|---|---|
| Pages (from-to) | 651-652 |
| Number of pages | 2 |
| Journal | Clinical and Experimental Dermatology |
| Volume | 39 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Jul 2014 |
Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis
A. C. Kai, C. Flohr, C. E. Grattan
Research output: Contribution to journal › Letter › peer-review
21
Citations
(Scopus)